A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Published in the journal JAMA, the study compared patients with Type 2 diabetes who were treated with…
[ad_2]
Source link
